Lv7
3420 积分 2021-10-14 加入
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients
2天前
已完结
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies
6天前
已完结
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
8天前
已完结
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
8天前
已完结
Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials
10天前
已完结
PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway
15天前
已完结
[Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China（2024 edition）]
15天前
已完结
[Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)]
16天前
已完结
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
17天前
已完结
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
21天前
已完结
皖公网安备34019202002308
